MDimune under spotlight for precise drug delivery technology eyes IPO in 2022
이 글자크기로 변경됩니다.
(예시) 가장 빠른 뉴스가 있고 다양한 정보, 쌍방향 소통이 숨쉬는 다음뉴스를 만나보세요. 다음뉴스는 국내외 주요이슈와 실시간 속보, 문화생활 및 다양한 분야의 뉴스를 입체적으로 전달하고 있습니다.
The startup founded in 2015 aims to load various drugs onto BioDrone in cooperation with domestic and foreign pharmaceutical companies to treat cancer, autoimmune diseases and other incurable conditions, the company’s president Bae Shin-gyu told Maeil Business Newspaper in a recent interview.
In May, MDimune signed a license agreement with Reyon Pharmaceutical over the BioDrone technology and agreed to jointly develop virus vaccines and treatments for rare genetic diseases. An additional license deals with another Korean pharmaceutical company is forthcoming. The recent business achievements will pave the way for the company’s IPO plan in the second half of next year, Bae said.
If a cancer therapy is loaded onto the exosome and put into the body, the exosome transports the drug to the area where the treatment is needed to cure the disease.
In the early days of MDimune, there were only 10 exosome-related companies in the world, but the number has sharply increased to about 20 in Korea and more than 200 around the world.
Bae received a master’s degree in fermentation engineering from KAIST and worked as a senior researcher and a technology evaluator. Bae decided to start his own business after discovering the potential of exosomes as new therapy technology for precision medicine while watching his mother struggling with chemotherapy.
MDimune has secured a proprietary technology to mass-produce exosomes in cells using extrusion technology through Postech. The company has registered patents for this technology in five countries, including Korea and the United States.
[ⓒ Maeil Business Newspaper & mk.co.kr, All rights reserved]
Copyright © 매일경제 & mk.co.kr. 무단 전재, 재배포 및 AI학습 이용 금지
- STARTUP FOCUS: Telemedicine app Dr. Now attracts $8.37 mn in series A funding - Pulse by Maeil Business News Korea
- Money supply surges by near record pace in Aug in Korea amid asset frenzy - Pulse by Maeil Business News Korea
- Enchem to expand capacity in China and Hungary through IPO proceeds - Pulse by Maeil Business News Korea
- S. Korea’s job conditions significantly improve, payroll increase biggest in seven yrs - Pulse by Maeil Business News Korea
- S. Korea to introduce independent container freight index: customs office chief - Pulse by Maeil Business News Korea
- 강경준, 상간남 피소…사랑꾼 이미지 타격 [MK픽] - 스타투데이
- 고난의 세월 딛고…수주 대박 두산에너빌
- 럭비 국대 출신 방송인, 옛 연인 강간·상해 혐의로 구속 - MK스포츠
- 이찬원, 이태원 참사에 "노래 못해요" 했다가 봉변 당했다 - 스타투데이
- 양희은·양희경 자매, 오늘(4일) 모친상 - 스타투데이